January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 30, 2026
U.S. Next Generation Sequencing Market (By Product Type: Sequencing Instruments, Consumables & Reagents, Software & Informatics Tools, Services; By Application: Clinical Diagnostics, Drug Discovery & Development, Research & Academia, Agrigenomics/Animal & Plant Genomics, Other Applications; By End-User: Hospitals & Diag...
April 29, 2026
RNA Analysis Market (By Technology / Methodology: RT-qPCR, Bulk RNA-Seq, Single-cell RNA-Seq, Digital PCR, Microarrays / Gene Expression Arrays, Targeted RNA Panels, Targeted RNA Panels, Other; By Product / Offering: Reagents & Kits, Instruments & Sequencers, Consumables, Software & Bioinformatics / Data Analysis, Software & Bioinfo...
April 28, 2026
ENT Devices Market (By Product Type: Diagnostic ENT Devices, Surgical ENT Devices, Hearing Aids & Implants, Voice & Speech Devices, Nasal Devices, Airway Management Devices, Others; By Application: Hearing Loss, Sinusitis, Sleep Apnea & Snoring, Otitis Media, Tinnitus, Allergic Rhinitis, Tonsillitis & Laryngitis, Skull Base & Co...
April 28, 2026
Biostimulants Market (By Active Ingredient: Acid Based, Seaweed Extract, Microbial, Others; By Crop Type: Row Crops & Cereals, Fruits & Vegetables, Turf & Ornamentals, Others; By Application: Foliar Treatment, Soil Treatment, Seed Treatment; By Region: North America, Asia Pacific, Europe, Latin America, Middle East and Africa) Global An...
April 27, 2026
U.S. Bispecific Antibody Market (By Therapeutic Area/Indication: Oncology, Immuno-inflammation/Autoimmunity, Infectious Diseases, Ophthalmology/Rare Diseases/Others; By Format/Architecture: Dual-variable/IgG-based bispecifics, T-cell Engagers, Bispecific Fc-fusion/Fc-silent multispecifics, Trispecific/multispecific/conjugated bispecifics, Bispecifi...
April 27, 2026
microRNA Market (By Products & Services: Services, Products; By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others; By End-use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Others; By Region: North America, Asia Pacific, Europe, L...
April 24, 2026
Fragment Analysis Market (By Product & Service: Instruments, Reagents & Consumables, Services; By Technology: Capillary Electrophoresis, Polymerase Chain Reaction, DNA Sequencing, Others; By Application: Genotyping & Polymorphism Analysis, Molecular Diagnostics, Forensic & Paternity Testing, Agricultural & Animal Genomics, Other...
April 21, 2026
The next-generation metabolic therapies market is witnessing strong expansion and is expected to generate revenue in the hundreds of millions during the forecast period from 2026 to 2035, driven by rising cases of metabolic disorders such as obesity, diabetes, NAFLD/NASH, and cardiometabolic syndrome....
April 21, 2026
According to market projections, the rotavirus vaccines market was valued at USD 5.25 billion in 2025 and is projected to grow from USD 5.78 billion in 2026 to USD 13.79 billion by 2035, registering a CAGR of 10.14% during the forecast period. The report covers detailed segment-wise data by vaccine type, route of administration, immunization progra...
April 21, 2026
Market insights predict the recombinant albumin market was valued at USD 152.9 million in 2025 and is projected to grow from USD 162.2 million in 2026 to USD 275.89 million by 2035, registering a CAGR of 6.08% during the forecast period. The report provides detailed insights into market size, growth trends, dosage form segments, application segment...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com